Keros Therapeutics (KROS) Cash from Investing Activities Growth (1y) (2020 - 2025)
Keros Therapeutics (KROS) Cash from Investing Activities Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 62.68% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -674.01% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -166.24% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Keros Therapeutics | 383.01 Mn | 95.61 Mn | - | 53.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 53.63% |
| Sep 30, 2025 | 65.80% |
| Jun 30, 2025 | -132.26% |
| Mar 31, 2025 | 40.27% |
| Dec 31, 2024 | 46.58% |
| Sep 30, 2024 | 29.82% |
| Jun 30, 2024 | 0.32% |
| Mar 31, 2024 | 10.92% |
| Dec 31, 2023 | -54.13% |
| Sep 30, 2023 | -212.50% |
| Jun 30, 2023 | 45.15% |
| Mar 31, 2023 | -622.45% |
| Dec 31, 2022 | -120.75% |
| Sep 30, 2022 | -21.38% |
| Jun 30, 2022 | -11.18% |
| Mar 31, 2022 | 30.00% |
| Dec 31, 2021 | -165.00% |
| Sep 30, 2021 | -383.33% |
| Jun 30, 2021 | -1,721.43% |
| Mar 31, 2021 | -19.32% |